Home › Funds
Hedge funds tracked by WhaleCreep
139 managers, chosen for public reputation, manager lineage and measured concentration rather than for any performance claim; see how the list is built. Sorted by the size of the reported US equity book. Latest quarter on file: Q2 2026.
| Manager | Style | Latest quarter | Equity book | Positions | Top position | Top 10 | Effective N | Quarters |
|---|---|---|---|---|---|---|---|---|
| Bloom Tree Partners behind | Emerging, concentrated | Q2 2023 | $214.7bn | 44 | 9.3% | 66.0% | 17.34 | 43 |
| Citadel Advisors | lch_top20 | Q2 2026 | $174.1bn | 6351 | 7.6% | 15.7% | 128.1 | 2 |
| D. E. Shaw & Co | lch_top20 | Q2 2026 | $161.8bn | 3463 | 6.5% | 19.2% | 124.69 | 2 |
| Millennium Management | lch_top20 | Q2 2026 | $148.1bn | 3841 | 7.3% | 19.0% | 121.18 | 2 |
| Marshall Wace | lch_top20 | Q2 2026 | $118.5bn | 2719 | 25.2% | 40.3% | 14.79 | 2 |
| Berkshire Hathaway | Permanent capital | Q2 2026 | $90.8bn | 29 | 14.2% | 91.5% | 9.79 | 111 |
| Baillie Gifford | Quality compounder | Q2 2026 | $89.0bn | 273 | 10.7% | 40.1% | 36.53 | 111 |
| WCM Investment Management | Quality compounder | Q2 2026 | $74.0bn | 266 | 11.4% | 51.9% | 24.77 | 110 |
| Renaissance Technologies LLC | Watchlist | Q2 2026 | $72.6bn | 3140 | 2.0% | 12.0% | 302.11 | 53 |
| Point72 Asset Management LP | Watchlist | Q2 2026 | $65.4bn | 1978 | 2.6% | 14.3% | 236.33 | 49 |
| Coatue Management | Tiger lineage | Q2 2026 | $63.8bn | 66 | 21.9% | 74.8% | 9.77 | 88 |
| TCI Fund Management | lch_top20 | Q2 2026 | $52.8bn | 11 | 33.6% | 98.6% | 5.24 | 2 |
| Holocene Advisors | Emerging, concentrated | Q2 2026 | $43.7bn | 782 | 7.6% | 26.5% | 73.0 | 35 |
| First Manhattan | Concentrated value | Q2 2026 | $39.2bn | 742 | 26.3% | 52.6% | 12.28 | 111 |
| Viking Global Investors | Tiger lineage | Q2 2026 | $35.1bn | 90 | 6.3% | 35.7% | 43.84 | 100 |
| D1 Capital Partners | Tiger lineage | Q2 2026 | $34.8bn | 55 | 61.9% | 76.7% | 2.58 | 31 |
| Woodline Partners | Emerging, concentrated | Q2 2026 | $32.4bn | 1011 | 3.3% | 17.2% | 175.32 | 27 |
| Sands Capital Management | Quality compounder | Q2 2026 | $26.9bn | 71 | 10.4% | 47.6% | 27.27 | 106 |
| Bridgewater Associates | Macro / discretionary | Q2 2026 | $24.4bn | 997 | 16.3% | 40.0% | 25.2 | 83 |
| Tudor Investment | Macro / discretionary | Q2 2026 | $24.2bn | 1679 | 5.0% | 20.2% | 137.87 | 109 |
| Tiger Global Management | Tiger lineage | Q2 2026 | $24.0bn | 46 | 9.7% | 67.1% | 17.69 | 98 |
| Situational Awareness | Macro / discretionary | Q2 2026 | $20.2bn | 23 | 28.1% | 92.1% | 5.63 | 2 |
| Alkeon Capital Management | Tiger lineage | Q2 2026 | $19.5bn | 79 | 14.9% | 61.8% | 16.68 | 92 |
| Farallon Capital Management | Emerging, concentrated | Q2 2026 | $17.1bn | 86 | 14.9% | 55.7% | 19.27 | 113 |
| Lone Pine Capital | Tiger lineage | Q2 2026 | $16.4bn | 34 | 7.2% | 53.9% | 22.57 | 87 |
| Elliott Investment Management | Activist | Q2 2026 | $14.3bn | 17 | 27.9% | 95.6% | 6.03 | 26 |
| Pershing Square Capital Management behind | Activist | Q1 2026 | $13.7bn | 11 | 17.6% | 99.9% | 6.94 | 82 |
| Fundsmith | Quality compounder | Q2 2026 | $13.6bn | 41 | 7.0% | 52.5% | 22.35 | 55 |
| Pentwater Capital Management | Emerging, concentrated | Q2 2026 | $12.5bn | 59 | 22.1% | 74.3% | 10.98 | 75 |
| Whale Rock Capital Management | Tiger lineage | Q2 2026 | $12.5bn | 35 | 10.9% | 59.3% | 20.34 | 79 |
| Polen Capital Management | Quality compounder | Q2 2026 | $11.6bn | 219 | 6.9% | 58.7% | 22.65 | 110 |
| RA Capital Management | Emerging, concentrated | Q2 2026 | $11.6bn | 84 | 23.7% | 60.0% | 12.9 | 73 |
| Atreides Management | Emerging, concentrated | Q2 2026 | $11.1bn | 46 | 41.9% | 76.3% | 5.15 | 27 |
| Maverick Capital | Tiger lineage | Q2 2026 | $11.1bn | 177 | 5.5% | 43.7% | 32.88 | 104 |
| Rubric Capital Management | Emerging, concentrated | Q2 2026 | $10.9bn | 87 | 12.7% | 46.4% | 26.64 | 39 |
| SRS Investment Management | Tiger lineage | Q2 2026 | $10.7bn | 32 | 24.1% | 73.5% | 10.6 | 63 |
| Egerton Capital | Concentrated value | Q2 2026 | $10.4bn | 23 | 14.1% | 76.0% | 13.92 | 52 |
| Durable Capital Partners | Tiger lineage | Q2 2026 | $10.3bn | 36 | 10.7% | 59.1% | 20.68 | 27 |
| Altimeter Capital Management | Tiger lineage | Q2 2026 | $9.8bn | 20 | 19.2% | 83.3% | 10.37 | 59 |
| Sculptor Capital Management | lch_top20 | Q2 2026 | $9.7bn | 320 | 6.4% | 34.2% | 52.79 | 2 |
| Gardner Russo & Quinn | Concentrated value | Q2 2026 | $8.9bn | 85 | 12.1% | 80.0% | 13.08 | 85 |
| Horizon Kinetics | Concentrated value | Q2 2026 | $8.8bn | 350 | 48.6% | 77.5% | 4.01 | 43 |
| Greenhaven Associates | Concentrated value | Q2 2026 | $8.7bn | 28 | 11.8% | 79.1% | 13.23 | 109 |
| Select Equity Group behind | Emerging, concentrated | Q3 2013 | $8.6bn | 80 | 5.7% | 39.6% | 37.33 | 52 |
| Soros Fund Management | Macro / discretionary | Q2 2026 | $7.6bn | 254 | 3.7% | 27.6% | 74.49 | 114 |
| Findlay Park Partners | Quality compounder | Q2 2026 | $7.4bn | 49 | 3.7% | 33.0% | 41.19 | 82 |
| Brevan Howard Capital Management | lch_top20 | Q2 2026 | $7.1bn | 1914 | 12.6% | 29.7% | 48.05 | 2 |
| Falcon Edge Capital | Tiger lineage | Q2 2026 | $6.2bn | 25 | 85.5% | 98.5% | 1.36 | 55 |
| Davidson Kempner Capital Management | lch_top20 | Q2 2026 | $6.2bn | 231 | 12.0% | 33.6% | 40.69 | 2 |
| Markel Group | Permanent capital | Q2 2026 | $6.0bn | 130 | 18.6% | 64.6% | 13.14 | 75 |
| ValueAct Capital | Activist | Q2 2026 | $5.6bn | 18 | 14.1% | 86.7% | 11.27 | 73 |
| Abrams Capital Management | Concentrated value | Q2 2026 | $5.5bn | 11 | 47.1% | 100.0% | 3.76 | 82 |
| Baupost Group | Concentrated value | Q2 2026 | $5.4bn | 23 | 16.5% | 74.9% | 13.45 | 104 |
| Junto Capital Management | Emerging, concentrated | Q2 2026 | $5.4bn | 80 | 3.4% | 27.9% | 58.09 | 47 |
| Ancora Advisors | Activist | Q2 2026 | $5.2bn | 2040 | 6.4% | 30.8% | 63.57 | 71 |
| Skye Global Management | Tiger lineage | Q2 2026 | $5.1bn | 30 | 44.8% | 85.0% | 4.43 | 35 |
| Akre Capital Management | Quality compounder | Q2 2026 | $5.1bn | 19 | 20.0% | 87.9% | 10.16 | 100 |
| Glenview Capital Management | Activist | Q2 2026 | $5.0bn | 42 | 12.9% | 64.1% | 17.86 | 98 |
| Sachem Head Capital Management | Activist | Q2 2026 | $4.8bn | 19 | 10.9% | 74.5% | 15.02 | 51 |
| Suvretta Capital Management | Emerging, concentrated | Q2 2026 | $4.8bn | 95 | 10.8% | 44.6% | 29.27 | 51 |
| Smead Capital Management | Concentrated value | Q2 2026 | $4.7bn | 32 | 7.1% | 54.2% | 22.88 | 74 |
| Third Point | Activist | Q2 2026 | $4.7bn | 42 | 11.5% | 60.5% | 19.08 | 108 |
| Brave Warrior Advisors | Concentrated value | Q2 2026 | $4.6bn | 40 | 11.9% | 74.4% | 14.44 | 56 |
| Starboard Value | Activist | Q2 2026 | $4.5bn | 21 | 15.1% | 84.3% | 11.9 | 61 |
| Appaloosa Management behind | Macro / discretionary | Q4 2015 | $4.4bn | 51 | 9.9% | 59.0% | 20.98 | 11 |
| Moore Capital Management | Macro / discretionary | Q2 2026 | $4.4bn | 715 | 2.3% | 17.7% | 143.51 | 72 |
| Duquesne Family Office LLC | Watchlist | Q2 2026 | $4.4bn | 86 | 19.9% | 52.4% | 17.08 | 53 |
| Altarock Partners | Concentrated value | Q2 2026 | $4.2bn | 8 | 32.2% | 100.0% | 4.24 | 47 |
| Trian Fund Management | Activist | Q2 2026 | $4.2bn | 8 | 35.6% | 100.0% | 3.86 | 62 |
| Icahn Capital behind | Activist | Q1 2011 | $4.2bn | 18 | 22.7% | 95.2% | 6.65 | 14 |
| Himalaya Capital Management | Concentrated value | Q2 2026 | $3.7bn | 8 | 24.5% | 100.0% | 5.08 | 35 |
| Tremblant Capital | Emerging, concentrated | Q2 2026 | $3.5bn | 58 | 4.5% | 37.1% | 38.64 | 83 |
| Boston Omaha behind | Permanent capital | Q4 2024 | $3.3bn | 335 | 5.4% | 34.3% | 53.19 | 96 |
| Vulcan Value Partners | Quality compounder | Q2 2026 | $3.3bn | 36 | 11.3% | 76.6% | 15.04 | 63 |
| Steadfast Capital Management | Tiger lineage | Q2 2026 | $3.3bn | 84 | 6.7% | 42.7% | 35.55 | 93 |
| Corvex Management | Activist | Q2 2026 | $3.2bn | 24 | 15.5% | 78.5% | 12.99 | 59 |
| Caxton Associates behind | Macro / discretionary | Q4 2024 | $3.1bn | 475 | 27.1% | 63.8% | 9.12 | 104 |
| Gates Capital Management | Concentrated value | Q2 2026 | $3.0bn | 31 | 5.2% | 47.8% | 26.35 | 87 |
| Giverny Capital | Concentrated value | Q2 2026 | $3.0bn | 51 | 7.2% | 51.5% | 26.25 | 46 |
| Lansdowne Partners | Concentrated value | Q2 2026 | $2.9bn | 26 | 36.3% | 95.2% | 4.77 | 48 |
| Dragoneer Investment Group | Tiger lineage | Q2 2026 | $2.8bn | 12 | 48.2% | 98.4% | 3.48 | 47 |
| Lindsell Train | Quality compounder | Q2 2026 | $2.6bn | 28 | 17.5% | 90.7% | 9.72 | 67 |
| Anomaly Capital Management | Emerging, concentrated | Q2 2026 | $2.6bn | 24 | 13.1% | 77.7% | 13.38 | 23 |
| Senator Investment Group | Emerging, concentrated | Q2 2026 | $2.6bn | 58 | 9.5% | 49.4% | 27.44 | 65 |
| Contour Asset Management | Emerging, concentrated | Q2 2026 | $2.6bn | 27 | 16.3% | 86.4% | 10.67 | 63 |
| Discovery Capital Management | Macro / discretionary | Q2 2026 | $2.4bn | 113 | 19.6% | 49.7% | 18.27 | 79 |
| Voss Capital | Concentrated value | Q2 2026 | $2.0bn | 35 | 12.0% | 66.5% | 17.19 | 27 |
| Casdin Capital | Emerging, concentrated | Q2 2026 | $2.0bn | 43 | 24.2% | 77.4% | 9.05 | 43 |
| Sylebra Capital behind | Tiger lineage | Q3 2023 | $1.9bn | 20 | 16.9% | 83.8% | 10.56 | 35 |
| Hite Hedge Asset Management | Emerging, concentrated | Q2 2026 | $1.8bn | 124 | 6.1% | 44.2% | 35.81 | 55 |
| Greenlight Capital behind | Concentrated value | Q4 2023 | $1.8bn | 40 | 19.7% | 76.8% | 11.75 | 100 |
| Fairholme Capital Management | Concentrated value | Q2 2026 | $1.5bn | 13 | 76.4% | 99.8% | 1.65 | 110 |
| Impactive Capital | Activist | Q2 2026 | $1.4bn | 8 | 30.0% | 100.0% | 5.73 | 27 |
| Irenic Capital Management | Activist | Q2 2026 | $1.4bn | 43 | 9.6% | 61.9% | 19.44 | 15 |
| JANA Partners behind | Activist | Q2 2023 | $1.3bn | 9 | 21.1% | 100.0% | 6.74 | 83 |
| Tweedy Browne | Concentrated value | Q2 2026 | $1.3bn | 91 | 17.1% | 69.2% | 13.42 | 110 |
| Ensemble Capital Management behind | Quality compounder | Q3 2024 | $1.2bn | 22 | 8.3% | 66.5% | 17.34 | 69 |
| Arlington Value Capital behind | Concentrated value | Q1 2020 | $1.2bn | 16 | 39.0% | 97.8% | 4.9 | 30 |
| Owl Creek Asset Management | Emerging, concentrated | Q2 2026 | $1.1bn | 31 | 49.4% | 80.6% | 3.82 | 74 |
| Bares Capital Management behind | Concentrated value | Q3 2025 | $1.1bn | 24 | 17.9% | 96.4% | 8.84 | 51 |
| Melqart | Emerging, concentrated | Q2 2026 | $1.1bn | 40 | 11.6% | 59.8% | 20.73 | 35 |
| Long Pond Capital | Tiger lineage | Q2 2026 | $953.9m | 30 | 16.6% | 69.3% | 14.77 | 59 |
| Bronte Capital | Emerging, concentrated | Q2 2026 | $888.2m | 56 | 12.3% | 74.4% | 14.89 | 31 |
| Semper Augustus Investments Group | Concentrated value | Q2 2026 | $884.6m | 50 | 15.5% | 78.9% | 13.12 | 75 |
| Hound Partners | Tiger lineage | Q2 2026 | $862.9m | 32 | 16.4% | 83.3% | 10.64 | 83 |
| Light Street Capital Management | Tiger lineage | Q2 2026 | $850.7m | 27 | 12.7% | 67.5% | 17.03 | 55 |
| Cantillon Capital Management | Concentrated value | Q2 2026 | $665.1m | 27 | 10.6% | 61.7% | 18.99 | 90 |
| Broad Run Investment Management | Quality compounder | Q2 2026 | $649.7m | 24 | 19.9% | 79.2% | 10.37 | 55 |
| Kahn Brothers | Concentrated value | Q2 2026 | $632.7m | 48 | 18.5% | 78.7% | 11.33 | 53 |
| Avidity Partners | Emerging, concentrated | Q2 2026 | $624.4m | 45 | 32.8% | 81.9% | 6.39 | 27 |
| Land & Buildings Investment Management | Activist | Q2 2026 | $583.4m | 19 | 9.8% | 72.8% | 15.43 | 58 |
| Alta Fox Capital Management | Concentrated value | Q2 2026 | $497.2m | 15 | 19.9% | 89.3% | 9.24 | 19 |
| Southeastern Asset Management | Concentrated value | Q2 2026 | $475.1m | 47 | 9.0% | 61.2% | 19.82 | 109 |
| Miller Value Partners | Concentrated value | Q2 2026 | $423.1m | 56 | 8.8% | 52.8% | 26.07 | 75 |
| Engaged Capital | Activist | Q2 2026 | $327.1m | 10 | 23.1% | 100.0% | 7.09 | 51 |
| Biglari Capital | Permanent capital | Q2 2026 | $293.9m | 12 | 36.8% | 100.0% | 4.05 | 52 |
| Palogic Value Management | Emerging, concentrated | Q2 2026 | $282.4m | 181 | 9.5% | 36.2% | 46.03 | 15 |
| Politan Capital Management | Activist | Q2 2026 | $255.0m | 2 | 53.7% | 100.0% | 1.99 | 19 |
| Pabrai Investment Funds behind | Concentrated value | Q4 2011 | $235.5m | 13 | 16.2% | 97.1% | 9.05 | 29 |
| Bridger Capital | Tiger lineage | Q2 2026 | $201.5m | 65 | 8.0% | 51.9% | 27.26 | 35 |
| Wynnefield Capital behind | Concentrated value | Q3 2011 | $173.3m | 30 | 16.8% | 81.1% | 12.1 | 43 |
| Greenhaven Road Capital | Concentrated value | Q2 2026 | $154.0m | 17 | 14.4% | 91.6% | 10.58 | 27 |
| Praetorian Capital behind | Concentrated value | Q1 2023 | $135.2m | 17 | 24.9% | 94.4% | 5.85 | 2 |
| Cook & Bynum Capital Management | Quality compounder | Q2 2026 | $134.5m | 6 | 41.2% | 100.0% | 3.48 | 59 |
| Nightview Capital | Quality compounder | Q2 2026 | $133.5m | 14 | 31.2% | 87.1% | 7.21 | 35 |
| Scopia Capital Management | Activist | Q2 2026 | $111.7m | 19 | 10.0% | 74.4% | 15.08 | 81 |
| Cove Street Capital behind | Quality compounder | Q3 2025 | $76.6m | 96 | 10.5% | 47.1% | 27.95 | 56 |
| Legion Partners Asset Management | Activist | Q2 2026 | $40.6m | 2 | 57.8% | 100.0% | 1.95 | 39 |
| Tybourne Capital Management behind | Tiger lineage | Q3 2025 | $30.9m | 4 | 39.1% | 100.0% | 3.0 | 52 |
| Blue Ridge Capital behind | Tiger lineage | Q3 2022 | $30.6m | 17 | 15.1% | 76.5% | 12.32 | 15 |
| Kingstown Capital Management behind | Concentrated value | Q3 2022 | $30.4m | 47 | 94.9% | 98.4% | 1.11 | 48 |
| Marcato Capital Management behind | Activist | Q4 2019 | $1.2m | 1 | 100.0% | 100.0% | 1.0 | 33 |
| Tiger Eye Capital behind | Tiger lineage | Q3 2022 | $0 | 1 | 77.0% | 90.3% | 1.68 | 40 |
| Marlin Sands Capital behind | Tiger lineage | Q3 2025 | $0 | 1 | 84.2% | 100.0% | 1.39 | 24 |
| Eminence Capital | Emerging, concentrated | Q2 2026 | $0 | 1 | 7.7% | 55.6% | 22.57 | 105 |
| Deep Basin Capital behind | Emerging, concentrated | Q1 2021 | $0 | 1 | 10.5% | 62.4% | 18.6 | 10 |
| Ruane Cunniff behind | Concentrated value | Q1 2018 | $0 | 1 | 9.0% | 56.6% | 22.06 | 76 |
| Blue Harbour Group behind | Activist | Q3 2020 | $0 | 1 | 34.8% | 100.0% | 4.31 | 59 |
| Inclusive Capital Partners behind | Activist | Q3 2025 | $0 | 1 | 100.0% | 100.0% | 1.0 | 20 |